June 10 (Reuters) - Adalta Ltd 1AD.AX :
* RECEIVES APPROVAL TO COMMENCE PHASE I CLINICAL TRIAL OF AD-214
* FIRST HEALTHY VOLUNTEER SUBJECT EXPECTED TO RECEIVE AD-214 IN LATE JULY
* TOP-LINE SAFETY RESULTS FROM HEALTHY VOLUNTEER COMPONENT EXPECTED AT BEGINNING OF CY2021